Published in Synapse on March 01, 1993
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci U S A (2006) 1.19
Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis. Brain Res (2007) 0.81
The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates. Exp Neurol (2007) 0.81
Opioid modulation of GABA release in the rat inferior colliculus. BMC Neurosci (2004) 0.76
Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res (1990) 1.33
Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. Biochem Biophys Res Commun (1983) 1.23
Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. J Pharmacol Exp Ther (1992) 1.03
Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol (2001) 1.01
Neuropeptide FF, pain and analgesia. Eur J Pharmacol (1998) 1.00
High resolution radioautographic localization of [125I]FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience (1991) 0.99
The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia. Eur J Pharmacol (1984) 0.94
Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol (1993) 0.90
Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands. Life Sci (1983) 0.89
Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226. Br J Pharmacol (2001) 0.87
Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor. Eur J Pharmacol (1997) 0.86
Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands. Neuroscience (2002) 0.84
[(125)I]EYF: a new high affinity radioligand to neuropeptide FF receptors. Peptides (2001) 0.83
Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice. Eur J Pharmacol (1998) 0.83
Differences in binding properties of mu and delta opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides. J Neurochem (1985) 0.82
Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur J Pharmacol (1992) 0.82
The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro. Mol Pharmacol (1982) 0.82
Highly directional emission from a quantum emitter embedded in a hemispherical cavity. Opt Lett (2015) 0.81
Characterization of a potent agonist for NPFF receptors: binding study on rat spinal cord membranes. Neuropharmacology (1994) 0.81
[125I][D-Ala2]deltorphin-I: a high affinity, delta-selective opioid receptor ligand. Peptides (1992) 0.81
Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity. J Med Chem (1994) 0.81
Effects of ibogaine on naloxone-precipitated withdrawal in morphine-dependent mice. Fundam Clin Pharmacol (1992) 0.81
Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs. Eur J Pharmacol (2000) 0.81
Biovector nanoparticles improve antinociceptive efficacy of nasal morphine. Pharm Res (2000) 0.81
Enkephalin-degrading enzymes and angiotensin-converting enzyme in human and rat meninges. FEBS Lett (1987) 0.81
Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies. Andrologia (2009) 0.81
Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones. Neuroreport (1996) 0.80
Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br J Pharmacol (1996) 0.80
Opioid receptor subtypes in the rat spinal cord: electrophysiological studies with mu- and delta-opioid receptor agonists in the control of nociception. Brain Res (1987) 0.80
Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience (1992) 0.80
Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex. Biochem Biophys Res Commun (1986) 0.80
Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul Pept (1995) 0.79
Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus. Eur J Pharmacol (1997) 0.79
Pre- and postsynaptic location of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord. Prog Clin Biol Res (1990) 0.79
Differential modulation of mu- and delta-opioid antinociception by neuropeptide FF receptors in young mice. Neuropeptides (1997) 0.79
Structure-activity relationships of neuropeptide FF: role of C-terminal regions. Peptides (2001) 0.79
Neuropeptide FF receptors in rat brain: a quantitative light-microscopic autoradiographic study using [125I][D.Tyr1, (NMe)Phe3]NPFF. Synapse (1996) 0.79
Neuropeptide FF: new molecular insights. Trends Pharmacol Sci (2001) 0.79
Effects of F8Famide analogs on intestinal transit in mice. Peptides (1993) 0.79
Nociceptin receptors in the rat spinal cord during morphine tolerance. Brain Res (1999) 0.78
Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins. Eur J Pharmacol (1989) 0.78
Effect of 1DMe, a neuropeptide FF analog, on acetylcholine release from myenteric plexus of guinea pig ileum. Jpn J Pharmacol (2001) 0.78
Are neuropeptides FF and SF neurotransmitters in the rat? Biochem Biophys Res Commun (2000) 0.78
Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats. Neuropeptides (1995) 0.78
Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol Biochem Behav (1997) 0.78
Involvement of locus coeruleus projections in opiate withdrawal but not in opiate tolerance in mice. Eur J Pharmacol (1996) 0.78
Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects. Brain Res (1987) 0.78
Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats. J Pharmacol Exp Ther (1993) 0.78
Autoradiographic characterization of rat spinal neuropeptide FF receptors by using [125I][D.Tyr1, (NMe)Phe3]NPFF. Brain Res Bull (1997) 0.78
Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res (1994) 0.78
Neuropeptide FF receptors of mouse olfactory bulb: binding properties and stimulation of adenylate cyclase activity. Peptides (1997) 0.78
Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Brain Res Dev Brain Res (1994) 0.78
A radioiodinated 7alpha-O-iodoallyl diprenorphine for mapping opioid receptors. Neuropeptides (1999) 0.77
Comparative binding properties of linear and cyclic delta-selective enkephalin analogues: [3H]-[D-Thr2, Leu5] enkephalyl-Thr6 and [3H]-[D-Pen2, D-Pen5] enkephalin. FEBS Lett (1985) 0.77
Differential depressive action of two mu and delta opioid ligands on neuronal responses to noxious stimuli in the thalamic ventrobasal complex of rat. Brain Res (1986) 0.77
Lack of significant changes in mu, delta opioid binding sites and neutral endopeptidase EC 3.4.24.11 in the brain and spinal cord of arthritic rats. Neuropharmacology (1989) 0.77
Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF. Regul Pept (2001) 0.77
Ontogeny of mu and delta opioid receptors and of neutral endopeptidase in human spinal cord: an autoradiographic study. J Chem Neuroanat (1990) 0.77
Presence of neuropeptide FF receptors on primary afferent fibres of the rat spinal cord. Neuroscience (1996) 0.77
Cerebellar opiate receptors in lagomorphs. Demonstration, characterization and regional distribution. Brain Res (1979) 0.77
Evaluation of [125I]7 alpha-O-iodoallyl diprenophine as a new potential SPECT opioid receptor imaging agent. Nucl Med Biol (1997) 0.77
Opiate receptor sites in the rabbit cerebellum: autoradiographic distribution. J Recept Res (1980) 0.77
Characterization of a new radioiodinated probe for the alpha2C adrenoceptor in the mouse brain. Neurochem Int (2000) 0.76
Evidence for multiple opioid receptors in the human posterior pituitary. J Neuroendocrinol (1996) 0.76
Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone. Neuroscience (1993) 0.76
Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides (2001) 0.76
The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology (1999) 0.76
The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord. Eur J Pharmacol (2001) 0.76
Species differences in the localization of neuropeptide FF receptors in rodent and lagomorph brain and spinal cord. Peptides (1996) 0.76
Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides (1998) 0.76
Effects of repeated treatment with haloperidol on rat striatal neutral endopeptidase, and on mu- and delta-opioid binding sites: comparison with chronic morphine and chronic kelatorphan. Neurosci Lett (1989) 0.76
Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats. Br J Pharmacol (1999) 0.76
[3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreas. Life Sci (1985) 0.76
Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides. J Med Chem (1988) 0.76
Irreversible labelling of delta-opioid receptors in rat brain and neuroblastoma cells by [3H]azido-DTLET: characterization of subunits and autoradiographic visualization of the covalent binding. Neuropeptides (1987) 0.75
The use of (3H) DAGO to label projections of thin primary afferent fibres at the superficial dorsal horn level of the rat spinal cord. Prog Clin Biol Res (1990) 0.75
Distribution of neuropeptide FF (FLFQPQRFamide) receptors in the adult rat spinal cord: effects of dorsal rhizotomy and neonatal capsaicin. Neuroscience (1995) 0.75
Differential properties of mu and delta opiate binding sites studied with highly selective ligands. Life Sci (1983) 0.75
Dual localization of neuropeptide FF receptors in the rat dorsal horn. Synapse (2000) 0.75
Improved quantitative radioautography of rat brain ?-opioid binding sites using [(3)H]DSTBULET, a new highly potent and selective linear enkephalin analogue. Neurochem Int (1990) 0.75
Dopaminergic control of gene transcription during striatal ontogeny: c-fos induction by D1 receptor activation in the developing striosomes. Brain Res Mol Brain Res (1995) 0.75
Modulation of mu opioid binding sites in rat spinal cord by chronic intrathecal infusion of morphine and naloxone: a quantitative autoradiography approach. Prog Clin Biol Res (1990) 0.75
Effects of cysteamine and of irradiation on microsomal membrane-bound enzymes. Enzyme (1982) 0.75
Synthesis, characterization and biodistribution of a new technetium-99m complex with trimethylsilylmethylisonitrile. Comparison with 99mTc-TBI and 99mTc-MIBI. Nucl Med Biol (1995) 0.75
Synthesis, characterization and biodistribution of new 99mTc Oxo and nitrido complexes of unsaturated tetradentate (N2S2)ligands. Nucl Med Biol (1993) 0.75
Technetium labeling of bi, tri and tetradentate ligands derived from 2-aminocyclopentene-1-dithiocarboxylic acid: characterization and biodistribution of their oxo and nitrido 99mtechnetium complexes. Nucl Med Biol (1996) 0.75
Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography. Neuropeptides (1993) 0.75